Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05318274 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Mar 30, 2026 to Dec 30, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jun 30, 2026 to Dec 30, 2026
    • Site details revised
    v3
  2. Primary completion date: Sep 30, 2022 to Mar 30, 2026
    • Study completion date: Mar 31, 2023 to Jun 30, 2026
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An explanatory study comparing complementary treatment to breast conservative surgery with radiation therapy DCIS, T1-T2 N0 M0 (AJCC v8) 1 week schedule vs 3.1 weeks standard schedule, in order to determine the equivalence of local tumor control, survival, acute and chronic toxicity. Shorter curse of radiation therapy may lead to similar local control of tumor cells and lower rates of toxicity than 3.1 standard treatment.
Trial Details
NCT Number NCT05318274
Lead Sponsor Coordinación de Investigación en Salud, Mexico
Conditions
(from sponsor)		 Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer, Stage 0 Breast Cancer, Stage I Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer
Related terms Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov